CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T-cell non-Hodgkin lymphoma: A first-in-human phase I clinical trial (NCT06420089).

Authors: Stefan K. Barta, Stephen J. Schuster, Jakub Svoboda, Jordan Spencer Carter, Elise A. Chong, Daniel J. Landsburg, Sunita Dwivedy Nasta, Ruchi Patel, Joseph A. Fraietta, Colin Thomas, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Anthony Siciliano, Marco Ruella, Rosemary Mazanet

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps7087

Source: Full article

---

Abstract

TPS7087